Natural vs Synthesized CBD: Nalu Bio s Synthesized CBD Offers Therapeutic Equivalency with Significant Advantages prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
SAN FRANCISCO, March 4, 2021 /PRNewswire/ Nalu Bio, Inc. today announced a collaboration with Ken Mackie, M.D., Chair and Distinguished Professor at Indiana University s Gill Center for Biomolecular Science, to evaluate how the potency and efficacy of the company s proprietary synthetic cannabinoids - specifically their close-to-market cannabidiol (CBD) - may enable the development of effective non-opioid pain management.
Nalu Bio. Learning from nature, delivering through chemistry. I am excited to bring a new category of chemistry-derived cannabinoids to patients worldwide -Prof. Mackie
Nalu Bio has developed a proprietary chemistry platform that enables highly efficient commercial production of organically synthesized cannabinoids. The collaboration with Prof. Mackie aims to demonstrate that synthetic CBD has the same potency and efficacy as plant-derived CBD.